IN2015DN02782A - - Google Patents

Info

Publication number
IN2015DN02782A
IN2015DN02782A IN2782DEN2015A IN2015DN02782A IN 2015DN02782 A IN2015DN02782 A IN 2015DN02782A IN 2782DEN2015 A IN2782DEN2015 A IN 2782DEN2015A IN 2015DN02782 A IN2015DN02782 A IN 2015DN02782A
Authority
IN
India
Prior art keywords
composition
cancer
risk
nicotine
prevention
Prior art date
Application number
Other languages
English (en)
Inventor
Basil Rigas
Jason Rigas
Original Assignee
Basil Rigas
Jason Rigas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basil Rigas, Jason Rigas filed Critical Basil Rigas
Publication of IN2015DN02782A publication Critical patent/IN2015DN02782A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/068—Chewing gum characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
    • A61M15/008—Electronic counters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
    • A61M15/0083—Timers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F13/00—Appliances for smoking cigars or cigarettes
    • A24F13/02—Cigar or cigarette holders
    • A24F13/12—Cigar or cigarette holders combined with other objects, e.g. writing utensils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0085—Inhalators using ultrasonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Physiology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN2782DEN2015 2012-09-21 2013-09-23 IN2015DN02782A (enExample)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261703999P 2012-09-21 2012-09-21
US14/013,019 US20140088045A1 (en) 2012-09-21 2013-08-28 Product comprising a nicotine-containing material and an anti-cancer agent
PCT/US2013/061206 WO2014047569A2 (en) 2012-09-21 2013-09-23 Product comprising a nicotine-containing material and an anti-cancer agent

Publications (1)

Publication Number Publication Date
IN2015DN02782A true IN2015DN02782A (enExample) 2015-09-04

Family

ID=50339457

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2782DEN2015 IN2015DN02782A (enExample) 2012-09-21 2013-09-23

Country Status (9)

Country Link
US (2) US20140088045A1 (enExample)
EP (1) EP2916847A4 (enExample)
JP (1) JP2015531793A (enExample)
KR (1) KR20150084794A (enExample)
CN (1) CN104918621A (enExample)
CA (1) CA2885739A1 (enExample)
EA (1) EA201590585A1 (enExample)
IN (1) IN2015DN02782A (enExample)
WO (1) WO2014047569A2 (enExample)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011133867A2 (en) * 2010-04-23 2011-10-27 The Regents Of The University Of Colorado, A Body Corporate Vaccines, methods of administering vaccines, methods and products for treating and/or delaying onset of dysplastic lesions, and wafers for oral administration
CA2822738C (en) 2010-12-22 2021-06-08 Exonoid Medical Devices Ltd. Method and system for drug delivery
FR3015186A1 (fr) * 2014-03-11 2015-06-26 Antoine Piccirilli Utilisation d'une composition renfermant du 1,3-propanediol comme e-liquide
WO2015148649A2 (en) * 2014-03-26 2015-10-01 Basil Rigas Systems and methods for ameliorating the effects of tobacco products
EP3129024A4 (en) * 2014-04-08 2017-11-22 Sansa Corporation (Barbados) Inc. Nicotine formulations and methods of making the same
KR102428028B1 (ko) 2014-04-28 2022-08-03 필립모리스 프로덕츠 에스.에이. 향미를 가진 니코틴 분말 흡입기
MX381937B (es) 2014-04-28 2025-03-13 Philip Morris Products Sa Inhalador de polvo de nicotina.
BR112016022476B1 (pt) 2014-04-28 2021-10-13 Philip Morris Products S.A. Inalador de pó de nicotina e método de inalação de nicotina para os pulmões de um usuário
US9896429B2 (en) 2014-05-27 2018-02-20 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
EP3871515B1 (en) 2014-05-27 2025-04-16 R. J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
US10508096B2 (en) 2014-05-27 2019-12-17 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
GB2527597B (en) * 2014-06-27 2016-11-23 Relco Induction Dev Ltd Electronic Vapour Inhalers
US11298477B2 (en) 2014-06-30 2022-04-12 Syqe Medical Ltd. Methods, devices and systems for pulmonary delivery of active agents
EP3160565B1 (en) 2014-06-30 2021-08-18 Syqe Medical Ltd. Devices and systems for pulmonary delivery of active agents
IL294075A (en) 2014-06-30 2022-08-01 Syqe Medical Ltd Flow regulating inhaler
BR112016030829B1 (pt) 2014-06-30 2022-02-22 Syqe Medical Ltd Cartucho de dosagem para dispositivo inalador
WO2016001922A1 (en) * 2014-06-30 2016-01-07 Syqe Medical Ltd. Methods, devices and systems for pulmonary delivery of active agents
MX2017000057A (es) 2014-06-30 2017-06-30 Syqe Medical Ltd Procedimiento y dispositivo para vaporizacion e inhalacion de sustancias aisladas.
CN113115993A (zh) 2014-10-29 2021-07-16 奥驰亚客户服务有限责任公司 用于电子烟装置的无乙醇凝胶配方筒体
WO2016069903A1 (en) 2014-10-29 2016-05-06 Altria Client Services Llc E-vaping cartridge
CN104544542B (zh) * 2014-12-24 2017-04-26 广西中烟工业有限责任公司 一种真空冷冻干燥薄荷粒电子烟油的制备方法
GB2534210B (en) * 2015-01-19 2017-07-19 Ngip Res Ltd Aerosol-generating article
BR112017022201A2 (pt) 2015-04-15 2018-07-03 Sansa Corporation (Barbados) Inc. dispositivo para adicionar um componente de aroma ou supressor de tosse a um inalador, inalador de pó seco, e, método para inalação de pó seco
US10149844B2 (en) 2015-09-16 2018-12-11 Philip Morris Products S.A. Inhalable nicotine formulations, and methods of making and using thereof
US9585835B1 (en) * 2015-09-16 2017-03-07 Sansa Corporation (Barbados) Inc. Inhalable nicotine formulations and methods of making and using the same
CN108495563B (zh) * 2015-11-25 2022-04-26 R.J.雷诺兹烟草公司 烟碱盐、共晶体和盐共晶体配合物
CA3008211A1 (en) 2015-12-24 2017-06-29 Philip Morris Products S.A. Nicotine powder delivery system
CN117695207A (zh) 2015-12-24 2024-03-15 菲利普莫里斯生产公司 带香味尼古丁粉末
WO2017109678A1 (en) 2015-12-24 2017-06-29 Philip Morris Products S.A. Nicotine particle capsule
CA3009599A1 (en) 2016-01-06 2017-07-13 Syqe Medical Ltd. Low dose therapeutic treatment
US9867397B2 (en) 2016-01-11 2018-01-16 Patrick Beymer Nicotine delivery system
GB201602831D0 (en) 2016-02-18 2016-04-06 British American Tobacco Co Flavour delivery device
PL3481471T3 (pl) 2016-07-07 2021-01-11 Philip Morris Products S.A. Układ inhalatora nikotyny
US20180036496A1 (en) * 2016-08-02 2018-02-08 James Riviello Medication Delivery System
US20220087305A1 (en) * 2018-12-28 2022-03-24 Philip Morris Products S.A. High viscosity nicotine formulation
US20220071268A1 (en) * 2018-12-28 2022-03-10 Philip Morris Products S.A. Nicotine formulation comprising metal salt
JP7551621B2 (ja) * 2018-12-28 2024-09-17 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 低モル質量金属塩を含む液体ニコチン製剤
EP3973794A4 (en) * 2019-05-21 2022-12-21 Japan Tobacco Inc. PERFUMED FILM FOR HEATED AROMA INHALER AND HEATED AROMA INHALER
WO2021126313A1 (en) * 2019-07-15 2021-06-24 The Research Foundation For The State University Of New York Nicotine materials, methods of making same, and uses thereof
LU101519B1 (en) * 2019-12-02 2021-06-07 Herrera Arturo Solis (S)-3-[1-MethyIpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a solid substance and a tablet
WO2022102543A1 (ja) * 2020-11-13 2022-05-19 日本たばこ産業株式会社 センブラトリエンジオールを含むたばこ抽出物およびその製造方法
KR20230158005A (ko) 2021-03-18 2023-11-17 씨젠 인크. 생물학적 활성 화합물의 내재화된 접합체로부터의 선택적 약물 방출
WO2024090890A1 (ko) * 2022-10-27 2024-05-02 주식회사 케이티앤지 흡입용 저용량 니코틴 건조 분말 조성물
WO2024194922A1 (ja) * 2023-03-17 2024-09-26 日本たばこ産業株式会社 香味組成物及び香味吸引器

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050236006A1 (en) * 2004-04-24 2005-10-27 Anderson Cowan Smoking cessation devices, methods of use and methods of conducting business therewith
JP5707131B2 (ja) * 2007-08-10 2015-04-22 リーガス，バジル 抗炎症性化合物とその用途
US20100124560A1 (en) * 2008-11-14 2010-05-20 Mcneil Ab Multi portion intra-oral dosage form and use thereof
WO2011133215A1 (en) * 2010-04-19 2011-10-27 Health Research Inc. Method of identifying and treating a person having a predisposition to or afflicted with parkinson disease
WO2011133475A2 (en) * 2010-04-19 2011-10-27 Sri International Compositions and method for the treatment of multiple myeloma

Also Published As

Publication number Publication date
KR20150084794A (ko) 2015-07-22
CN104918621A (zh) 2015-09-16
US20140088045A1 (en) 2014-03-27
WO2014047569A2 (en) 2014-03-27
US20140088044A1 (en) 2014-03-27
EP2916847A2 (en) 2015-09-16
WO2014047569A3 (en) 2014-07-17
EA201590585A1 (ru) 2016-04-29
CA2885739A1 (en) 2014-03-27
EP2916847A4 (en) 2016-06-08
JP2015531793A (ja) 2015-11-05
WO2014047569A9 (en) 2014-05-30

Similar Documents

Publication Publication Date Title
IN2015DN02782A (enExample)
WO2015148649A3 (en) Systems and methods for ameliorating the effects of tobacco products
PH12012500540A1 (en) Improved device and method for delivery of a medicament
MX2009009428A (es) Analogos de ciclopamina heterociclicos y metodos de uso de los mismos.
MY162514A (en) Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors
MX2009009429A (es) Analogos de ciclopamina lactama y metodos de uso de los mismos.
MD20150035A2 (ro) Inhibitori de tirozinkinaza Bruton
WO2014062720A3 (en) Methods of treating cancer
SG10201811128RA (en) Ezh2 inhibitors for treating lymphoma
UA118113C2 (uk) Пептидоміметичні сполуки та їх кон'югати антитіла з лікарським засобом
NZ748451A (en) Methods for treating atopic dermatitis by administering an il-4r antagonist
PH12014501815A1 (en) Purinone compounds as kinase inhibitors
PH12012502399A1 (en) Combination therapy methods for treating proliferative diseases
NZ700759A (en) Combination therapy for treating cancer
MX2011011126A (es) Composiciones y metodos para tratar quemaduras.
MY181602A (en) Isochromene derivatives as phosphoinositide 3-kinases inhibitors
TNSN07193A1 (en) Pharmaceutical compositions comprising a camptothecin derivate
WO2012005885A3 (en) Nutraceutical product containing anatabine and yerba maté
MX2015000347A (es) Derivados de estra-1,3,5(10),16-tetraeno 3-sustituidos, metodos para su preparacion, preparaciones farmaceuticas que los contienen, asi como su uso para la preparacion de medicamentos.
IN2015DN03854A (enExample)
NZ711564A (en) Methods of treating colorectal cancer
MY171526A (en) Pharmaceutical formulation for reducing frequency of urination and method of use thereof
IN2014DN09437A (enExample)
PH12017500505A1 (en) Veliparib in combination with carboplatin and paclitaxel for the treatment of non-small cell lung cancer in smokers
HK1199832A1 (en) Combination therapy using ribavirin as eif4e inhibitor